Atea Pharmaceuticals, Inc. (AVIR)
4.65
+0.06
(+1.31%)
USD |
NASDAQ |
Feb 24, 16:00
4.66
+0.01
(+0.22%)
Pre-Market: 20:00
Atea Pharmaceuticals Shareholders Equity (Annual) : 438.87M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Oramed Pharmaceuticals, Inc. | 146.26M |
| Aclaris Therapeutics, Inc. | 155.55M |
| PMV Pharmaceuticals, Inc. | 176.08M |
| Instil Bio, Inc. | 169.44M |
| Coya Therapeutics, Inc. | 39.58M |